Boise, ID, United States of America

Christopher R Ritchie

This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Micron Technology Incorporated, Lodestar Licensing Group LLC. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher R Ritchie. Retrieved from https://idiyas.com/inventor/christopher-r-ritchie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Inventive Journey of Christopher R Ritchie

Introduction: Christopher R Ritchie is a prolific inventor based in Boise, Idaho, known for his groundbreaking contributions to various industries.

Latest Patents: Christopher R Ritchie holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Christopher R Ritchie has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing unique solutions.

Collaborations: Throughout his career, Christopher R Ritchie has collaborated with leading companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Christopher R Ritchie's passion for innovation and his relentless drive to push the boundaries of what is possible make him a standout figure in the world of inventors, with a legacy that continues to inspire future generations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…